Erweiterte Suche

Matthew Goldberg is currently working as the Vice President-Medical at Castle Biosciences, Inc. He previously worked as an Assistant Professor at Icahn School of Medicine at Mount Sinai.
Dr. Goldberg has a graduate degree from Princeton University and a doctorate degree from Icahn School of Medicine at Mount Sinai.

Matthew Goldberg is the founder of Pliant.io, Inc. He is currently serving as the Chief Operating Officer of the company since 2018.

Matthew L.
Goldberg served as Secretary, Vice President & General Counsel at Concentrix SREV, Inc. from 2013 to 2015.
He graduated from The Wharton School of the University of Pennsylvania with an undergraduate degree, and from Temple University Japan and George Washington University Law School with graduate degrees.

Matthew Goldberg currently works as a Director at Wentworth-Douglass Physician Corp.

Matthew A. Goldberg ist Mitglied des Vorstands von TeamSnap, Inc. und Burning Man Project sowie Executive Vice President-Global Operations bei The Trade Desk, Inc. In seiner bisherigen Laufbahn war Matthew Goldberg Director-Strategic Planning bei der Illinois Housing Development Authority (Illinois), Chief Executive Officer von Lonely Planet Publications Pty Ltd, Senior VP-Digital Strategy & Operations bei Dow Jones & Co, Inc, Senior Vice President-Corporate Development bei QVC, Inc, Development Director bei Bertelsmann, Inc. und Vice President-Franchise Development bei The Wall Street Journal, Inc. Herr Goldberg erhielt einen Undergraduate-Abschluss von der Cornell University, einen Graduate-Abschluss von der University of Melbourne und einen MBA von der Stanford Graduate School of Business.

Michael R.
Goldberg joined Theravance, Inc. as Vice President of Clinical Pharmacology in September 2005.
From 1988 to 2005, he was Senior Director of Safety/Clinical Risk Management and Safety Surveillance for Merck and worked at Eli Lilly in the Clinical Pharmacology Department.
Dr. Goldberg received his MD and PhD degrees from Tulane University, School of Medicine and completed his Clinical Pharmacology fellowship at the Vanderbilt University School of Medicine.